KCT0003997
Not yet recruiting
未知
Clinical Trial to Assess the Effectiveness and to Safety of UC in the Patients with Ischemic Stroke: a multi-center randomized controlled pilot trial)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyung Hee University
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Men and women who are not pregnant nor breastfeeding, aged 19 to 80 years
- •(2\) Patients diagnosed with acute ischemic stroke in brain image(MR or CT)
- •(3\) Patients participating within 90 days of the onset
- •(4\) Patients with upper or lower limb weakness (Fugl\-Meyer Assessment (FMA) motor score \= 55 and 1\= Medical Research Council Scale score (at least one arm or leg motor power grade) \=4\)
- •(5\) Patients with mild to moderate ischemic stroke (4\= Korean version of the National Institute of Health Stroke Scale (K\-NIHSS) score \=15\)
- •(6\) modified Rankin Scale (mRS) score before the recent ischemic stroke \=1
- •(7\) Subject who have no communication problems and voluntary agree to participate
Exclusion Criteria
- •(1\) Patients with motor weakness caused by previous stroke
- •(2\) Patients diagnosed with degenerative brain disease(e.g., Parkinson's disease, Alzheimer's disease)
- •(3\) Patients diagnosed with hemorrhagic stroke(intracranial hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage) in brain image(MR or CT)
- •(4\) Taking amphetamine, Selective Serotonin Reuptake Inhibitors(SSRI), or antipsychotic medication
- •(5\) Patients with other brain disease (e.g., brain tumor, traumatic brain injury, arteriovenous malformation, moyamoya disease, and ischemic stroke caused by these disease, etc.)
- •(6\) Previous history of brain surgery
- •(7\) Patients who already have motor weakness due to other disease
- •(8\) Unstable vital signs at screening (e.g., systolic blood pressure (sBP) \=160mmHg, even though taking antihypertensive drugs)
- •(9\) Serious disease(e.g., liver disease, kidney disease, severe heart failure( \= New York Heart Association classification (NYHA) Class III), etc.)
- •(10\) Taking drugs that can cause liver or renal dysfunction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Contrast Enhanced Ultrasonography-guided Sentinel Lymph Node Biopsy after Introducing Twirl Breast Marker for Axillary Lymph Node-positive Breast CancerBreast cancerD001943JPRN-jRCTs051210034Miyake Tomohiro20
Recruiting
Phase 2
A Clinical Trial To Evaluate The Effectiveness Of Vasa Avaleha In Respiratory Symptoms As A Sequelae Of FeverCTRI/2023/07/055016I
Recruiting
Phase 2
A Clinical Trial To Evaluate The Action OF Duralabhadi Decoction In The Management Of Urinary Tract Infections.CTRI/2023/07/055121I
Recruiting
Phase 2
Effect of levetiracetam and topiramate in infantile spasmsIRCT20091027002639N21Yazd University of Medical Sciences60
Active, not recruiting
Not Applicable
The effectiveness and safety of oral adhesive bandage for extraction wound managementWound management in tooth extractionOral HealthISRCTN11589028Wuhan University120